Update in pulmonary hypertension 2005

被引：32

作者：

Hoeper, MM ^{[1
]}

Rubin, LJ

机构：

[1] Hannover Med Sch, Dept Resp Med, D-30623 Hannover, Germany

[2] Univ Calif San Diego, Pulm Vasc Program, La Jolla, CA 92093 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2006年 / 173卷 / 05期

关键词：

D O I：

10.1164/rccm.2512003

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：499 / 505

页数：7

共 92 条

[1] Lessons learned from cancer may help in the treatment of pulmonary hypertension [J].

Adnot, S .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (06) :1461-1463

[2] Role of prostacyclin versus peroxisome proliferator-activated receptor β receptors in prostacyclin sensing by lung fibroblasts [J].

Ali, FY ;

Egan, K ;

FitzGerald, GA ;

Desvergne, B ;

Wahli, W ;

Bishop-Bailey, D ;

Warner, TD ;

Mitchell, JA .

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 34 (02) :242-246

[3] Derivation and validation of a prognostic model for pulmonary embolism [J].

Aujesky, D ;

Obrosky, DS ;

Stone, RA ;

Auble, TE ;

Perrier, A ;

Cornuz, J ;

Roy, PM ;

Fine, MJ .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (08) :1041-1046

[4] Sitaxsentan therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

Langleben, D ;

Frost, A ;

Horn, EM ;

Oudiz, R ;

Shapiro, S ;

McLaughlin, V ;

Hill, N ;

Tapson, VF ;

Robbins, IM ;

Zwicke, D ;

Duncan, B ;

Dixon, RAF ;

Frumkin, LR .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) :441-447

[5] Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema [J].

Berger, MM ;

Hesse, C ;

Dehnert, C ;

Siedler, H ;

Kleinbongard, P ;

Bardenheuer, HJ ;

Kelm, M ;

Bärtsch, P ;

Haefeli, WE .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (06) :763-767

[6]

Bonderman D, 2005, CHEST, V128, P2599, DOI 10.1378/chest.128.4.2599

[7] Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension [J].

Bonderman, D ;

Jakowitsch, J ;

Adlbrecht, C ;

Schemper, M ;

Kyrle, PA ;

Schönauer, V ;

Exner, M ;

Klepetko, E ;

Kneussl, MR ;

Maurer, G ;

Lang, I .

THROMBOSIS AND HAEMOSTASIS, 2005, 93 (03) :512-516

[8] Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study [J].

Channick, RN ;

Simonneau, G ;

Sitbon, O ;

Robbins, IM ;

Frost, A ;

Tapson, VF ;

Badesch, DB ;

Roux, S ;

Rainisio, M ;

Bodin, F ;

Rubin, LJ .

LANCET, 2001, 358 (9288) :1119-1123

[9] Severe pulmonary hypertension and chronic obstructive pulmonary disease [J].

Chaouat, A ;

Bugnet, AS ;

Kadaoui, N ;

Schott, R ;

Enache, I ;

Ducoloné, A ;

Ehrhart, M ;

Kessler, R ;

Weitzenblum, E .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (02) :189-194

[10] Expression of human herpesvirus 8 in primary pulmonary hypertension [J].

Cool, CD ;

Rai, PR ;

Yeager, ME ;

Hernandez-Saavedra, D ;

Serls, AE ;

Bull, TM ;

Geraci, MW ;

Brown, KK ;

Routes, JM ;

Tuder, RM ;

Voelkel, NF .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) :1113-1122

← 1 2 3 4 5 6 7 8 9 10 →